Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Myelodysplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00326170
What this trial is testing

Phase II 5-Azacytidine Plus VPA Plus ATRA

Who this might be right for
Myelodysplastic SyndromeAcute Myelogenous Leukemia
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00439673
What this trial is testing

PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Gruppo Italiano Malattie EMatologiche dell'Adulto 62
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Testing effectiveness (Phase 2)Study completedNCT00566696
What this trial is testing

Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies

Who this might be right for
Leukemia, Acute Lymphocytic (ALL)Leukemia, Myeloid, Acute(AML)Leukemia, Myeloid, Chronic(CML)+5 more
St. Jude Children's Research Hospital 73
Large-scale testing (Phase 3)UnknownNCT02272478
What this trial is testing

Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations

Who this might be right for
Acute Myeloid LeukaemiaMyelodysplastic Syndrome
Cardiff University 1,600
Testing effectiveness (Phase 2)Study completedNCT01370213
What this trial is testing

NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 25
Early research (Phase 1)Study completedNCT05829226
What this trial is testing

Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
AML, Adult RecurrentMDS
PureTech 101
Testing effectiveness (Phase 2)Study completedNCT02649790
What this trial is testing

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Metastatic Colorectal Cancer (mCRC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)+3 more
Karyopharm Therapeutics Inc 277
Testing effectiveness (Phase 2)Study completedNCT01692197
What this trial is testing

E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT02029950
What this trial is testing

Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia-2High Risk Myelodysplastic Syndrome+1 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00860574
What this trial is testing

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+21 more
Fred Hutchinson Cancer Center 96
Not applicableStudy completedNCT00987584
What this trial is testing

Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk

Who this might be right for
Myelodysplastic Syndromes
Peter L Greenberg 13
Early research (Phase 1)Study completedNCT05564650
What this trial is testing

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeRecurrent Myelodysplastic SyndromeRefractory Myelodysplastic Syndrome
Thomas Jefferson University 6
Testing effectiveness (Phase 2)UnknownNCT04358393
What this trial is testing

APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDS

Who this might be right for
AMLAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+4 more
Ascentage Pharma Group Inc. 69
Testing effectiveness (Phase 2)Study completedNCT01760655
What this trial is testing

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62
Large-scale testing (Phase 3)Study completedNCT00071799
What this trial is testing

A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care

Who this might be right for
Myelodysplastic Syndromes
Celgene 358
Not applicableStudy completedNCT01872819
What this trial is testing

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+16 more
University of Washington 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03121014
What this trial is testing

Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
University of Illinois at Chicago 38
Testing effectiveness (Phase 2)Study completedNCT00628628
What this trial is testing

Rasburicase in Patients at Risk for Tumor Lysis Syndrome

Who this might be right for
Tumor Lysis Syndrome
M.D. Anderson Cancer Center 82
Next Page